PedAM
Pediatric Disease Annotations & Medicines
| Disease | diabetes mellitus, insulin-dependent |
| Phenotype | C0022658|kidney disease |
| Sentences | 18 |
| PubMedID- 21840097 | Sex differences in the development of kidney disease in individuals with type 1 diabetes mellitus: a contemporary analysis. |
| PubMedID- 24793984 | However, urine agt concentration has not been reported in type 1 diabetes with kidney disease. |
| PubMedID- 23303408 | Our objective was to study the effect of apelin on the progression of kidney disease in mice with established type 1 diabetes. |
| PubMedID- 26310691 | The presence and consequence of nonalbuminuric chronic kidney disease in patients with type 1 diabetes. |
| PubMedID- 24696459 | Nonalcoholic fatty liver disease is independently associated with an increased incidence of chronic kidney disease in patients with type 1 diabetes. |
| PubMedID- 22728293 | Background: simultaneous pancreas-kidney transplantation (spkt) is a promising therapy for type 1 diabetes mellitus with chronic kidney disease. |
| PubMedID- 21307382 | In the context of type 1 diabetes, and especially in patients with chronic kidney disease (ckd) who have the greatest risk of adverse outcomes (7,8), activation of these pathways may offset or overshadow any gains achieved from modest and transient blood pressure lowering. |
| PubMedID- 24165454 | Early treatment of hypertension has been reported to prevent end-stage kidney disease in patients with type 1 diabetes [121]. |
| PubMedID- 23919599 | In the present study, we investigated associations of single nucleotide polymorphisms (snps) in the regulatory regions of cybb and gpx4 with kidney disease in patients with type 1 diabetes. |
| PubMedID- 21883436 | Increased prevalence of chronic kidney disease in patients with type 1 diabetes and non-alcoholic fatty liver. |
| PubMedID- 22533709 | [36] reported that plasma ctgf was increased in type 1 diabetes subjects with kidney disease, compared to those with normoalbuminuria, but there were no significant associations of the −945 g/c polymorphism with plasma ctgf levels or cardiovascular mortality, non-fatal cardiovascular events and end-stage kidney disease. |
| PubMedID- 25027389 | Aims: improved early diagnostic methods are needed to identify risk for kidney disease in people with type 1 diabetes. |
| PubMedID- 26273678 | The patients suffering from cancer, acute inflammation, liver and kidney disease, patients with type 1 diabetes, and patients recently taking drugs that may interfere with glucose and lipid metabolism were not included in the present study. |
| PubMedID- 21698141 | For example, the 4.1 protein ezrin, radixin, moesin [ferm] domain containing 3 locus (frmd3) was implicated in kidney disease attributed to type 1 diabetes (t1dm) in european americans from the genetics of kidneys in diabetes (gokind) collection, with replication based upon nephropathy progression rates in subjects with t1dm in the diabetes control and complications trial (dcct)/epidemiology of diabetes interventions and complications (edic) study [17]. |
| PubMedID- 22540522 | Early detection of kidney disease in type 1 diabetes: what do we really know. |
| PubMedID- 23835686 | Our primary finding is a stepwise increased odds for cac progression in type 1 diabetes with progressive kidney disease and increased odds even with normal renal function. |
| PubMedID- 24455970 | Nonalcoholic fatty liver disease (nafld) is associated with an increased prevalence of chronic kidney disease in patients with type 1 diabetes. |
| PubMedID- 23028342 | New susceptibility loci associated with kidney disease in type 1 diabetes. |
Page: 1